Clinical Trial Update: Stellate Ganglion Blockade in Corona Virus 2019 (COVID-19) Positive Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating stellate ganglion blockade in COVID-19 patients with ARDS was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Stellate Ganglion Blockade

Snippet

Sponsor: University of Nebraska | Conditions: COVID 19, ARDS | Phase 1 | Status: TERMINATED | Results posted: 2025-01-20